Keith A Perry, MD in Smithfield, RI - Medicare Anesthesiology

Keith A Perry, MD is a medicare enrolled "Anesthesiology" physician in Smithfield, Rhode Island. He went to University Of Vermont College Of Medicine and graduated in 1985 and has 39 years of diverse experience with area of expertise as Anesthesiology. His current practice location is 14 Cedar Swamp Rd, Smithfield, Rhode Island. You can reach out to his office (for appointments etc.) via phone at (401) 231-0060.

Keith A Perry is licensed to practice in Rhode Island (license number MD07817) and he also participates in the medicare program. He may accept medicare assignments (which means he may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance) and his NPI Number is 1548214141.

Contact Information

	Keith A Perry, MD
	14 Cedar Swamp Rd, Smithfield, RI 02917-2448
	(401) 231-0060
	(401) 231-0064

Physician's Profile

Full Name	Keith A Perry
Gender	Male
Speciality	Anesthesiology
Experience	39 Years
Location	14 Cedar Swamp Rd, Smithfield, Rhode Island
Accepts Medicare Assignments	May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance.

Medical Education and Training:

Keith A Perry attended and graduated from University Of Vermont College Of Medicine in 1985

NPI Data:

NPI Number: 1548214141
Provider Enumeration Date: 05/19/2006
Last Update Date: 03/19/2018

Medicare PECOS Information:

PECOS PAC ID: 6901995851
Enrollment ID: I20111220000011

Medical Identifiers

Medical identifiers for Keith A Perry such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1548214141	NPI	-	NPPES
7002962	Medicaid	RI

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208VP0000X	Pain Medicine - Pain Medicine	MD07817 (Rhode Island)	Secondary
207L00000X	Anesthesiology	MD07817 (Rhode Island)	Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Keith A Perry allows following entities to bill medicare on his behalf.

Entity Name	Precision Pain Treatment Clinic, Llc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1033523063 PECOS PAC ID: 3870713639 Enrollment ID: O20140930001952

News Archive

Study reveals effective therapeutic strategy to prevent colorectal cancer progression

Nagoya University researchers and colleagues have revealed that colorectal cancer tissues contain at least two types of fibroblasts (a type of cells found in connective tissue), namely, cancer-promoting fibroblasts and cancer-restraining fibroblasts, and that the balance between them is largely involved in the progression of colorectal cancer.

Study finds metabolic syndrome may indicate breast cancer risk in post-menopausal women

Metabolic syndrome, associated with the sedentary lifestyle and energy dense diet of Western industrialized societies, may be an indicator of breast cancer risk in post-menopausal women, according to a new study to be released at the National Italian American Foundation event, "Let's Talk About It: A Spotlight on Women's Health" on October 22nd at the Washington Hilton in Washington, D.C.

Laurantis Pharma's Lymfactin rebuilds lymphatic vessels in pre-clinical animal models

Laurantis Pharma, a privately held biotechnology company based in Finland, today announced that Lymfactin, adenoviral VEGF-C growth factor therapy, was successful in rebuilding lymphatic vessels in pre-clinical animal models.

Genetic variation associated with increased risk of sudden cardiac arrest

A study by a global consortium of physician-scientists has identified a genetic variation that may predispose people to double the risk of having a sudden cardiac arrest, a disorder that gives little warning and is fatal in about 95 percent of cases.

Sanofi-Aventis acquires exclusive global rights to CureDM's Pancreate

CureDM, LLC announced today that an agreement has been signed with Sanofi-Aventis for the exclusive worldwide license of Pancreate™, a novel islet neogenesis agent for the treatment of type 1 and type 2 diabetes. CureDM is a privately held biopharmaceutical company whose scientists discovered Pancreate™, a first-in-class human peptide therapeutic. Several key Composition of Matter and Use patents have been issued to CureDM for this potentially transforming treatment approach for diabetes.

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Keith A Perry is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Keith A Perry, MD 14 Cedar Swamp Rd, Smithfield, RI 02917-2448 Ph: (401) 231-0060	Keith A Perry, MD 14 Cedar Swamp Rd, Smithfield, RI 02917-2448 Ph: (401) 231-0060

News Archive

Keith A Perry, MD - Medicare Anesthesiology in Smithfield, RI

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medicare Reassignments

Study reveals effective therapeutic strategy to prevent colorectal cancer progression

Study finds metabolic syndrome may indicate breast cancer risk in post-menopausal women

Laurantis Pharma's Lymfactin rebuilds lymphatic vessels in pre-clinical animal models

Genetic variation associated with increased risk of sudden cardiac arrest

Sanofi-Aventis acquires exclusive global rights to CureDM's Pancreate

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Study reveals effective therapeutic strategy to prevent colorectal cancer progression

Study finds metabolic syndrome may indicate breast cancer risk in post-menopausal women

Laurantis Pharma's Lymfactin rebuilds lymphatic vessels in pre-clinical animal models

Genetic variation associated with increased risk of sudden cardiac arrest

Sanofi-Aventis acquires exclusive global rights to CureDM's Pancreate

Anesthesiology Doctors in Smithfield, RI